GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (MEX:SNY N) » Definitions » Cyclically Adjusted Price-to-FCF

Sanofi (MEX:SNY N) Cyclically Adjusted Price-to-FCF : 15.78 (As of Jul. 02, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Sanofi Cyclically Adjusted Price-to-FCF?

As of today (2025-07-02), Sanofi's current share price is MXN919.00. Sanofi's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec24 was MXN58.25. Sanofi's Cyclically Adjusted Price-to-FCF for today is 15.78.

The historical rank and industry rank for Sanofi's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

MEX:SNY N' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 12.15   Med: 16.71   Max: 21.42
Current: 15.13

During the past 13 years, Sanofi's highest Cyclically Adjusted Price-to-FCF was 21.42. The lowest was 12.15. And the median was 16.71.

MEX:SNY N's Cyclically Adjusted Price-to-FCF is ranked better than
79.69% of 325 companies
in the Drug Manufacturers industry
Industry Median: 31.21 vs MEX:SNY N: 15.13

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sanofi's adjusted free cash flow per share data of for the fiscal year that ended in Dec24 was MXN51.167. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is MXN58.25 for the trailing ten years ended in Dec24.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sanofi Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Sanofi's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Cyclically Adjusted Price-to-FCF Chart

Sanofi Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.75 18.17 17.16 16.28 17.07

Sanofi Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.16 - 16.28 - 17.07

Competitive Comparison of Sanofi's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Sanofi's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanofi's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sanofi's Cyclically Adjusted Price-to-FCF falls into.


;
;

Sanofi Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Sanofi's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=919.00/58.25
=15.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanofi's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec24 is calculated as:

For example, Sanofi's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec24 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec24 (Change)*Current CPI (Dec24)
=51.167/119.9500*119.9500
=51.167

Current CPI (Dec24) = 119.9500.

Sanofi Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201512 43.597 100.040 52.274
201612 51.190 100.650 61.006
201712 49.748 101.850 58.589
201812 31.766 103.470 36.825
201912 49.409 104.980 56.455
202012 51.228 104.960 58.544
202112 78.122 107.850 86.887
202212 69.201 114.160 72.711
202312 54.159 118.390 54.873
202412 51.167 119.950 51.167

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sanofi  (MEX:SNY N) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Sanofi Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Sanofi's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi Business Description

Industry
Address
46, Avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Sanofi Headlines

No Headlines